Beta-Lactamase-Producing Gram-Negative Bacterial Isolates Among the Patients Attending a Tertiary Care Hospital, Kathmandu, Nepal
- PMID: 36713265
- PMCID: PMC9880579
- DOI: 10.1177/11786361221150761
Beta-Lactamase-Producing Gram-Negative Bacterial Isolates Among the Patients Attending a Tertiary Care Hospital, Kathmandu, Nepal
Abstract
Over the times, carbapenems have been the choice of drug for treating multidrug-resistant (MDR) and extended spectrum beta-lactamase (ESBL)-producing organisms. The current study aimed at determining the occurrence of metallo beta-lactamase (MBL) and AmpC beta-lactamase (ABL) in gram negative bacteria isolated from clinical samples. A cross-sectional study was conducted amongst the patients visiting Manmohan Memorial Medical College and Teaching Hospital (MMTH), Kathmandu, Nepal from August 2017 to January 2018. A total of 4351 samples including urine, pus, wound swab, endotracheal tip, catheter tip, and blood were collected from the patients and processed by standard conventional microbiological methods. Antibiotic susceptibility testing (AST) of the isolates was performed by Kirby-Bauer disk diffusion method. Double disc synergy test was performed on carbapenem resistant organisms to detect production of MBL and inhibitor-based test was used for the detection of ABL production. Of the 4351 samples, 421 bacterial isolates belonging to 16 different genera were recovered, of which 303 (71.97%) were Gram negative bacilli (GNB). E. coli (189/303) and S. aureus (80/118) were the most prevalent among gram negatives and gram positives, respectively. Bacterial incidence was found significantly associated with gender, specimen type, and the department where the patients were enrolled. Colistin-sulfate and polymycin-B were the most effective drug against GNB, whereas imipenem against gram positives. Prevalence of MDR and methicillin-resistant S. aureus (MRSA) was 35.15% and 60%, respectively. The prevalence of MBL and ABL-producing isolate was 11(3.6%) and 13(4.3%), respectively. Pseudomonas aeruginosa (5/11) and E. coli (9/13) were the major MBL and ABL producers, respectively. MBL and ABL production was found to be significantly associated with the age of the patient and the specimen type. A regular antibiotic surveillance activity with screening for MBL and ABL-producing bacterial isolates in the hospital settings to curb the incidence and transmission of such difficult-to-treat pathogens.
Keywords: AmpC; MBL; multidrug-resistant; β-lactams.
© The Author(s) 2023.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
Similar articles
-
Antibiotic resistance and detection of plasmid mediated colistin resistance mcr-1 gene among Escherichia coli and Klebsiella pneumoniae isolated from clinical samples.Gut Pathog. 2021 Jul 5;13(1):45. doi: 10.1186/s13099-021-00441-5. Gut Pathog. 2021. PMID: 34225805 Free PMC article.
-
Extended spectrum beta-lactamase and metallo beta-lactamase production among Escherichia coli and Klebsiella pneumoniae isolated from different clinical samples in a tertiary care hospital in Kathmandu, Nepal.Ann Clin Microbiol Antimicrob. 2017 Sep 19;16(1):62. doi: 10.1186/s12941-017-0236-7. Ann Clin Microbiol Antimicrob. 2017. PMID: 28927454 Free PMC article.
-
A hospital based surveillance of metallo-beta-lactamase producing gram negative bacteria in Nepal by imipenem-EDTA disk method.BMC Res Notes. 2017 Jul 25;10(1):322. doi: 10.1186/s13104-017-2640-7. BMC Res Notes. 2017. PMID: 28743282 Free PMC article.
-
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.Drugs. 2019 Feb;79(3):271-289. doi: 10.1007/s40265-019-1055-2. Drugs. 2019. PMID: 30712199 Review.
-
Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.Drugs. 2022 Apr;82(5):533-557. doi: 10.1007/s40265-022-01688-1. Epub 2022 Mar 16. Drugs. 2022. PMID: 35294769 Review.
Cited by
-
Antimicrobial Resistance Patterns and Risk Factors Associated with ESBL-Producing and MDR Escherichia coli in Hospital and Environmental Settings in Lusaka, Zambia: Implications for One Health, Antimicrobial Stewardship and Surveillance Systems.Microorganisms. 2023 Jul 31;11(8):1951. doi: 10.3390/microorganisms11081951. Microorganisms. 2023. PMID: 37630511 Free PMC article.
References
-
- Behera B, Mathur P, Das A, Kapil A, Sharma V. An evaluation of four different phenotypic techniques for detection of metallo-beta-lactamase producing Pseudomonas aeruginosa. Indian J Med Microbiol. 2008;26:233-237. - PubMed
-
- Adhikari S, Regmi RS, Pandey S, Paudel P, Neupane N. Bacterial etiology of bronchoalveolar lavage fluid in tertiary care patients and antibiogram of the isolates. J Inst Sci Technol. 2021;26:99-106.
-
- Adhikari S, Khadka S, Rana JC, et al.. Prevalence of β -lactamase producing carbapenem-resistant enterobacteriaceae among the patients attending Bharatpur hospital. Biosci Discov. 2019;10:64-71.
-
- Regmi RS, Khadka S, Sapkota S, et al.. Phenotypic detection of inducible clindamycin resistance among clinical isolates of staphylococcus aureus in Bharatpur hospital. J Coll Med Sci. 2020;16:178-183.
LinkOut - more resources
Full Text Sources
Miscellaneous